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of prcop-rative ischemia (4-6). Awareness of these risks 
and advancer in patient monitoring and anesthesia delivery 
have made the infraoprative period relatively safe. In 
contrast. myucardid ischeoda is more comroon sod more 
severe m the early postoperative phase (4.6). Perioperative 
The article by McFalls et al. (IL in this issue of the Joumal infarction is frequently silent and amy be diEcult to detect 
is another in a growing series of studies evaluating noninva clinically (71. Although non-Q wave infarction also often 
sive diagnostic tests for identifying surgical patient? at high occttrs m the 1st 2 postoperative days, in a pattern similar to 
risk for periaperative cardiovascular morbidity and monai- that of nchemic episodes, the peak iacideace of Q wave 
ity. Not only is this literature expanding, but the utdiaation infarctma may occur somewhat later. on postoperative day9 
of these tests is becoming more routine and has almost 2 to 4 (2.7-9). Congestive heart &lure and pulmonary edema 
certainly led to an increasing number of coronary revascu- commonly appear on day 3 or later. as a result of delayed 
larization procedures for the specific indica:ioa of mitigating mobilization of extmvascular volume in patients with pre- 
p&operative risk. The co.st implications of these trends are existing left ventricular systolic or diastolic dysloction. of 
profound, and therefore. it is important to critically ~valuatr as a consequence of superimposed &hernia or infarction. 
tbe rationale for p&operative diagnostic testing, the poten- SW& factors are responsible for the increased inci- 
tiaI approaches to such testing and the actual value of dence of postoperative ischemia (2). These include increased 
testing. adrenergic activity associated with discomfort. other physi. 
Magahttda of #be problem. Approximately 25 million cal and emotmnal suesso~s, withdrawal of anesthesia or 
patients undergo noncardiac surgery each year in the United medication. and altered vasomotor regulation. Other 
States: of these. 3 million have clinical evidence or multiale changes that may predispose to iscbemin are marked bemo- 
risk factors for coronwy artery disease and 4 million are ;65 
years old (2). Thus. nearly one of every three patients 
undergoing noncardiac sorgsry is at added risk for cardio- 
vascular complications. Indeed, approximately I million 
patients will have a cardiac death. myocatdiai infarction, 
unstable an&a pectoris or congestive heart failure after 
noncardiac surgery, and the w)st of in-hospital perioperative 
cardiac morbidity exceeds St0 billion annually in the U.S. 
(2.3). Thus, a great deal of thought and e5ort have been 
devoted to identifying patients at higb risk for cardiac 
complications. particularly among the subgroup of -W.ooO 
patients undergoing vascular surgery. who have a high 
incidence of aoaarent sod occult coronarv disease and are 
facing particui~ly stressful procedures. 
Pathaphysio@y of prkqterallve cardiac morbidity. The 
major cardiac complications of noncardiac surgery-death, 
dynamic Rucru&ns, b&y temperato~i abwxmalities, hy- 
poaemia. fluid shifts, activation of other neorohonoonal 
pathways and the postoperative hypercoagolable state. 
These physiologic responses produce myocadial ischemia 
by three often overlapping mechanisms: I) increased atyo- 
cardial metabolic demands in the presence of preexisting 
impaired coronw vascuiar reserve: 2) reduction of myocar- 
dial oxygen delivery due to diminished oxygen-carrying 
capactty. hypotension or coronary “asospasm; and 3) acute 
coronary occlusion due to thrombosis. 
Although coionary artery disease provides the substrate 
for each of these mecbaoisms of ischemia, the underlying 
pathology may differ among them. Thus, ischemia due to 
incwwzd metabolic demand is most likely to occur in 
patients with preexisting critical coronary stenoses or oc- 
cluded coronay arteries with myocaniium supplied by col- 
lateral vessels. Ischemia due to decreased oxygen supply 
may occur in these same patients, but it also may occur in 
patients with less critical stenoses. because it is quite likely 
that thrombotic occlusions cccor frequently in vessels that 
were previously not severely obstructed. as is the case for 
myocardial infarction in nonsurgical patients (IO). Patients 
developing heart failure and pulmonary edema. Thus, the 
presence ofcoronary disease. but not necessarily preexisting 
critical stenosis, is the substrate for most periopelative 
cardiac events. 
Predictors of cardiac risk. Clinical indicators. Several 
investigators have evaluated potential clinical indicators of 
increased cardiac risk in patients undergoing noncardiac 
surgery (2.7.11-14). Although the precise markers and the 
way in which they are weighted vary among the resulting 
multifactorial indexes, for each marker, the risk increases 
when the following factors are present: I) clinical evidence 
of cormxry anay disease, as indicated by angina pectoris 
or prior myocardial infarction; 2) severe left ventricular 
dysfunction, as evidenced by B history of heart failure, a 
third hean sound or elevated jugular venom pressure: or 
3) factors tkat increase the likelihood of these conditions, 
includingaavancedage,diabetesmellitus or exdiacatiyth- 
miss. The more unstable or uncontrolled the manifestations 
of coronary disease or other cardiac abnormalities, the 
higher the associated risk. These indexes have proved useful 
in identifying groups of patients at high and low risk for 
noncardiac procedures. However, when the patient group 
under evaluation is known to have a high orevalence of 
underlying apparent or silent coronary d&se, such as 
patients undergoing abdominal aorta or peripheral vascular 
surgery, a very low risk group cannot be identified by clinical 
markers alone (14). Even individuals with low risk scores 
may have a 5% to 10% incidence of cardiac complications. 
Noninvasive taring. As a result, the ability of a variety 
of noninvasive diagnostic procedures to predict p&pa+ 
tive risk has been evaluated over the last decade. Procedures 
that have been examined include exercise testing to diagnose 
ischemia and assess functional capacity, rest and exercise 
radionuclide angiogmpky, ambulatory electrocardiographic 
(ECG) assessment of &hernia. exercise and pharmacologic 
stress myocardial scintigraphy and stress echocardiography. 
Several recent articles (2,7,14) have reviewed tke results 
with these procedures. Of note is that the initial reports on 
each of these tests have been very favorable. ORen. virtually 
all of the complications have occurred in the minority of 
patients with a positive test result. This is the expected 
outcome for studies that include only a small number of 
patients and events, particularly when they arc conducted in 
a retrospective manner and patient data arc not withheld 
from the investigators. Furthermore. the bias of the publi- 
cation process, which favors positive results and new tech- 
niques. may also be responsible tar the uniformly favorable 
findings. Often, the first negative results concerning risk 
assessment by clinical indexes or noninvasive testing have 
been those that appeared by way of comparison with newer 
techniques. 
The most extensively studied noninvasive approach to 
the risk stratification of patients undergoing noncardiac 
surgery is dipyridamole thallium-201 scintigmphy, which is 
discussed in depth in the previously cited reviews (7.14). 
Several small and medium&cd studies, derived from rela- 
tively few institutions, have demonstrated that the risk of 
cardiac complication5 i( wbstantiallv increased in patients 
who have regions of hypoperfusion after dipyridamole injec- 
tion that normalize during delayed or subsequent rest or 
reinjection scintigrams. There appears to be a quantitative 
relation between the magnitude of reversible perfusion ab- 
nomulities and the degree of risk. In some of these studies, 
the ability to identify a patient group at low risk by virtue of 
absence of a reversible scintigraphic defect is truly rcmark- 
able. Also surprising is the lack of increased risk in patients 
with fixed scintigrapkic defects in most studies, because this 
finding usually indicates prior myocardial infarction and, in 
row cases. substantial left ventricular dysfunction US). 
More recent stuC. ; (16,17) have not always confirmed the 
initial ace~racy of dipyridamcde thallium-201 scintigraphy in 
predicting p-c&p&i& risk. Indeed, in a preliminary report 
of the largest prospective study to date (IS), reversible 
defects on dipyridamole thallium-201 scintigrapky failed to 
predict cardiac complications. This trend is not unexpected 
from data on both physiologic considerations and experience 
with other diagnostic tests. Because preexisting wronxy 
artery disease, but not necessarily critical coronary stenosis, 
is the substrate for myocardial infarction and most episodes 
of heart failure. cardiac complications should be anticipated 
in patients with fixed defects or even a negative study result. 
Furthermore, as pertoperative cardiac stresses can be se- 
vex, ischemia may wcur because of stcnoscs that arc not 
severe enough to produce defects with low levels of stress OT 
coronary vascdilation on preoperative testing. Finally, as 
with other noninvasive tests, less favorable results are also 
to be expected when these procedures enter a phase of more 
widespread use under less optimal conditions (19). 
Contribulkm d the prrsrnt study. Tke study by McFalls 
et al. (I) in the cwcnt issue of the Journal examines 
still another approach toward risk stratification, exercise 
thallium-201 scintigmphy, and raises provocative questions 
concerning the interpretation and value of noninvasive im- 
aging techniques in this setting. Although 116 men undergo- 
ing elective vascular surgery were included in the study, the 
important results concern the 88 patients who underwent 
either graded treadmill or arm ergometry exercise in con- 
junction withlhallium-201 scintigraphy. Scintigraphic nsults 
were abnormal in 46 (52%) of these, of whom 20 had 
reversible defects. II had fixed defects and 15 had partially 
reversible abnormalities. A high proportion of these pa- 
tients, 8%. subsequently sustcdned B p&operative myocar- 
dial infarction and, in contrast to previous studies with 
dipyridamole scintigrapky, the presence of a&d tkallium- 
201 defect was the only scintieraohic oredictor of this 
adverse outcome. . _ ’ ’ 
The explanation the authors offer for this provocative 
finding is that these fixed defects may represent severe 
&hernia withlittleredistributionduringthe 3. toCh interval 
allowed for delayed imaging. Although it is impossible to 
refute this suggestion, it is unlikely that all of the fixed 
defects can be explained by ischcmia. The propation of 
patients. 29%. exhibirinn fixed or onlv oaniallv reversible 
hcfccts is essentially id&al to the p&&ion (28%) with a 
history of prior myocardial infarction, and the failure of risk rtrattfication and that patients with intermediate risk by 
reversible defects to predict subsequent infarction ruggeests clinicai assessment may benefit from additional testing. 
that factors other than &hernia are responsible for these However, they also recognized that a very low risk group 
findings. Another interpretation of thebe results is that the may nor be identifiable when higk risk procedures such as 
low level of sfre~s obtained in these patients, either becase vasculv surgery are ptanned. Thus, they are more cautious 
treadmill exercise was limited by peripheral vascular disease in delineating a low risk group of patients who should oat 
or hecause arm ergometry is not an equivaient stress. limited cndzrg< .&tional testing and re&ving this strategy for 
the sensitivitv of thallium-201 scintimaohv to demonstrate patients wirhout clinical risk factors who are able to walk at 
reversible isckemia. Thus, a fixed d&c; may have been 
more important as an indicator of underlying coronary 
disease than as a marker of ischemia as such. Indeed. the 
presence of angina pectoris or clinical evidence of coronary 
disease also tended to identify those at risk for perioperativc 
infarction. Thus, the study of McFaJls et aI. may bernother 
in the recent group of scintigraphic studies indicating that a 
reversible defect, or indeed any defect, is not as sensitive a 
marker for perioperstive cardiac events BS was once 
thought. 
Risk stmtkicatton by nonkwmtve testing: when is it indi- 
eated? Patient s~rbgroups. From the foregoing discussion. 
it would seem that risk stratification of the patient undergo- 
ing noncardiac surgery remains an imperfect art. Clinical 
indexes can identify patients at high risk but not those at 
very low risk when the patient group has a high prevalence 
of coronary artery disease. such as patients undergoing 
vascular surgery. In more general usage, noninvasive teck- 
ttiques are unlikely to be as accurate as they were in the 
initial studies. U&s they can achieve n relatively high 
sensitivitv (well in excess of 50%) at an acceptable level of 
specifieit; in one’s own instirulion. they &e unlikely to 
justify their very high cost (well over SZW million if they are 
utilized in just 50% of patients undergoing only vascular 
procedures). Thecost ofsuck testing in the 7 million surgical 
patients with known coronary disease or important risk 
factors could easily exceed $10 billion, which equals the cost 
of managing perioperative cardiac complications. 
Two well considered approaches have been pmposed for 
more selective use of diagnostic testing or risk str&cati”n. 
Eagle et al. (20) have suggested that additional testing should 
be reserved for patients who, by clinical assessment, are at 
intermediate risk for cardiac complications. They identified 
five clinical factors that were ittdeoettdentlv oredictive of 
perioperative ctudiac complications~ age >ld y&s. ECG Q 
waves. diabetes mellitus, a history of ventricular arrhyth- 
mias and a history of angina pectoris. If three or more of 
these were present, the risk of complications was high 
enough so that additional testing was not considered war- 
ranted; similarly. if none were present, the patients were at 
such low risk that additional testing was considered of little 
value. Thus. they advocated limiting additional risk strutifi- 
cation to patients who had one or two of these factors and 
were thus at intermediate levels of risk. Of note is that this 
inlermediate group represented JS% of their series of pa- 
tients undergoing major vascular surgery. In a went review. 
Wang and Detsky (14) suggested a similar approach, con- 
cluding that clinically high risk patients do not need further 
ieast 2 blocks ,titkcxt c.--*- _, ...Y~ats. Uufo~unately, this would 
represr~t a very small percent of patients undergoing vas- 
Lular surgery. 
llrihry II: porienr mrmogement. A more difficult and 
muck more significant question coocems the utility cf risk 
stratification. Predicting risk is often considered a goat in 
itself. but IogicalIy there are only three indications for 
performing costly procedures to predict the risk of cardiac 
complications: I) the results would potentially lead to the 
cancellation of surgery or dictate a different opemtive pro- 
cedure (e.g.. amputation vs. peripheral arterial bypass); 
2) the results would potentially mandate performance of 
coronary revascularization before noncardiac surgery; 3) the 
results would alter management during the perioperative 
pCli”d 
How often. and with what justification, are the results of 
risk stratification procedures used for these purposes? w 
tions such as cancellation of surgery or the selection of a 
different procedure arc usually reserved for very high risk 
patients. In general, these patients can be identified by 
clinical assessment, and the results of noninvasive testinrfor 
myocardial ischemia would probably not affect this d&ion 
in m”*t cases. 
Theoretically. a patient identified as being at high risk for 
cardiac events would benefit from more intensiva perioper- 
ative monitoring and prophylactic anti-ischemic therapy. 
However, the value of kemodynamic or tmnsesoph~eal 
echocardiagmphic mouitorktg and prolonged observation in 
the intensive care unit in preventing these complications 
remains unproved (21). In practice, patients undergoing high 
risk procedures (vascular surgery, for example) or who are 
id&tied as being at kigh risk on clinical grounds are 
monitored more closely. Whether additional risk stmtilica- 
tion would lead to safer or mote wstcffectire periopaative 
care is a hypothesis that requires testing. Until suck abenelit 
is clear. this does not aopear to be an adequate justit?ation 
for risk stntitication. 6.t abut more a&es&e medical 
manaeement of Datients identified as being hii risk? Apain. - _ _ 
this is an attractive approach, but its value remains ub 
proved. Optimization of heart rate and arterial pressure in 
the periopentive period has become standard practice. It 
would be inappropriate to discontinue this practice in pa- 
ttents with clinical indicators of risk or in those undergoing 
high risk procedures on the basis of negative results on a 
noninvasive study. Although no medication Ls L~een nmved 
to reduce perioperative risk, empiric therapy with beta- 
adrenergic blocking agents has keen suggested (2). HOW- 
ever. potential candidates for tkis approach can probably be 
identified on clinical grounds, and an advantage to detecting 
them by scintigraphic techniques remains to be demon- 
stmted. 
The most controversial issue concerns prophylactic COT- 
onay revascularization. I” practice, a positive noninvasive 
test for ischemia often leads to coronary arteriography and 
revascularization. but this approach is not supported by data 
from clinical trials. Advocates have noted the low mortality 
and morhidity rates of patients who have undergone core- 
r*lry revascularizatio” and then subsequently have vascular 
surgery (221, but this analysis ignores the complication rate 
of the initial coronary procedure and the likely patient 
selection bias. It is essential that the strategy ofprophylactic 
coronary revasc”larization be tested in a prospective ran- 
domized trial. but until this is done. preoperative coronary 
revascularization should be reserved primarily for patients 
with the usual clinical indications for this procedure-those 
with unstable angina or symptom limitation on medical 
therapy. Patients deemed to be at high risk by clinical 
criteria may also be candidates for revascularization if 
extensive &hernia is demolislrdted and the coronary ana- 
tomical findings suggest that revascularization may prolong 
survial. Overall, however, in view of the unconfirmed 
benefit of prophylactic revascularization, identification of 
candidates does not appear to be adequate justification ior 
risk stratification in patients with no other indication for 
coronary revascularization. 
Conclusions. Perioperative cardiac morbidity and mortal- 
ity remain a major public health problem. A grow of high 
risk pafients can&lily be identitied by clinical c&ia, and 
noninvasive tests for &hernia can further stratify those at 
intermediate and low risk. However, it seems likely that the 
extremely favorable results observed in the initial studies of 
many techniques, and dipyridamole thallium-201 scintigra- 
phy in particular, may not reflect more general experience. 
More impwant, the rationale for risk stratification must 
be examined critically. It is a worthwhile goal only if it leads 
to a better outcome. Unfortunately, there are no data to 
support specific interventions in patients identified as being 
at high risk. Shouldn’t we demonsir& the &icacy of the 
therapy before we seek out potential candidates for it? The 
goal of risk stratification may be a multimillion dollar can 
leading a potentially multibillion dollar horse in an unknown 
direction. 
